Key result
Higher plasma CTRP9 linked to increased carotid IMT in T2D patients without chronic kidney disease.
Why the study?
Are plasma CTRP9 levels associated with carotid intima-media thickness in patients with type 2 diabetes?
Population
419 patients with type 2 diabetes, including 161 with chronic kidney disease (CKD)
Design
Cross-sectional
Authors
Loading...
CTRP9 measurement should not yet inform T2D management; leaves open its role as atherosclerosis biomarker pending longitudinal studies.
Observational (n=419)
Are plasma CTRP9 levels associated with carotid intima-media thickness in patients with type 2 diabetes?
Plasma CTRP9 levels are independently associated with atherosclerosis progression (measured by carotid IMT) in patients with type 2 diabetes without chronic kidney disease.
Asada et al. (2016) conducted an observational in Type 2 diabetes (n=419). Plasma CTRP9 levels was evaluated on Carotid intima-media thickness (IMT). Plasma CTRP9 levels were positively associated with carotid intima-media thickness in type 2 diabetes patients without chronic kidney disease, independent of traditional cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: